Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1993
11/09/1993CA1324132C Oxyimino derivatives of thiazole, method of preparation and use in therapy
11/09/1993CA1324131C 2-(heterocyclylalkyl)imidazopyridines
11/09/1993CA1324130C Oxaza heterocycles and pharmaceutical compositions containing same
11/09/1993CA1324129C Prostaglandins of the f series
11/09/1993CA1324128C 2', 2'-difluoronucleosides
11/09/1993CA1324098C Serum-free medium for the proliferation of lymphokine-activated killer cells
11/09/1993CA1324086C Methods and compositions for combatting herpes viruses
11/09/1993CA1324085C Nutritional supplement for treatment of cancer cachexia
11/09/1993CA1324084C Method of extracting a physiological active substance from the husks of pine nuts and anti-contagion medicine made of said extract as principal raw material
11/09/1993CA1324080C Bioadhesion drug carriers for endothelial and epithelial uptake and lesional localization of therapeutic and diagnostic agents
11/09/1993CA1324077C Additives enhancing topical actions of therapeutic agents
11/08/1993CA2095194A1 Quinazolines as inhibitors of hiv reverse transcriptase
11/07/1993CA2095375A1 Benzoate derivatives of taxol
11/07/1993CA2095174A1 Phenyl sulfonamide endothelin antagonists
11/06/1993CA2095509A1 Enantiomeres derives du (s)-amino-2-dichloro-3,4-benzyl) -2-propanol-1
11/06/1993CA2095505A1 Active principle based on avermectines, related strain and process for the preparation thereof, as well as veterinary composition containing it
11/03/1993EP0568437A1 Antidepressant 3-Halophenylpiperazinyl-propyl Derivatives of Substituted Triazolones and Triazoldiones
11/03/1993EP0568338A2 Methods for the use of spermidine/spermine N'-acetyltransferase as a progonostic indicator and/or a tumor response marker
11/03/1993EP0568323A1 Stable porfimer sodium compositions and methods for their manufacture
11/03/1993EP0568310A1 Composition comprising heparin and rapamycin
11/03/1993EP0568306A1 Anticonvulsant fructopyranose cyclic sulfites and sulfates
11/03/1993EP0568289A2 Benzothiophenes and thienothiophenes and related compounds useful, for example, as urokinase inhibitors
11/03/1993EP0568208A1 Treatment of neurodegenerative diseases
11/03/1993EP0568136A1 Indole-2-carboxylic acid derivatives
11/03/1993EP0568026A2 Piroxicam tablets and production process thereof
11/03/1993EP0567997A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical
11/03/1993EP0567982A1 Azole compounds, their production and use
11/03/1993EP0567968A1 Cyclic imino derivatives, medicaments containing these compounds and processes for the production thereof
11/03/1993EP0567967A1 Tritium-labelled fibrinogen-receptor-antagonists, their use and their production
11/03/1993EP0567966A1 Cyclic imino derivatives, medicaments containing these compounds and processes for the production thereof
11/03/1993EP0567767A1 Crystalline forms of endo-2,3-dihydro-N-(8-methyl-8-azabicyclo 3.2.1 oct-3-yl)-2-oxo-1H-benzimidazole-1-carboxamide hydrochloride monohydrate and of endo-3-ethyl-2,3-dihydro-N-(8-methyl-8-azabicyclo 3.2.1 oct-3-yl)-2-oxo-1H-benzimidazole-1-carboxamide hydrochloride monohydrate as 5-HT antagonists
11/03/1993EP0567703A1 Treatment of neurodegenerative diseases
11/03/1993EP0567653A1 Drug for hepatic diseases
11/03/1993EP0567626A1 Amylin agonist peptides and uses therefor
11/03/1993EP0567613A1 Compositions and methods for therapy and prevention of cancer, aids, and anemia
11/03/1993EP0567566A1 Methods for treating tumor necrosis factor mediated diseases
11/03/1993EP0567559A1 Anti-hiv activity of liposomal nystatin and amphotericin b
11/03/1993EP0567514A1 A METHOD AND A SYSTEM FOR ENHANCED $i(IN VIVO) CLEARANCE OF DIAGNOSTIC AND/OR THERAPEUTIC AGENTS BY EXTRACORPOREAL DEPLETION, AND THE USE OF SAID AGENTS FOR SAID PURPOSE
11/03/1993EP0567498A1 Pharmaceutical composition containing granisetron and dexamethasone
11/03/1993EP0567481A1 Cosmetic or pharmaceutical preparation
11/03/1993EP0567472A1 D-homo-(16-en)-11 beta-aryl-4-estrenes, process for producing them and their use as medicaments
11/03/1993EP0567470A1 Pseudomonas peptide composition and method for producing the same
11/03/1993EP0514491B1 Light-resistant filtering cosmetic composition containing a uv-a filter and an alkyl beta, beta-diphenylacrylate or an alkyl alpha-cyano-beta, beta-diphenylacrylate
11/03/1993EP0500793B1 Osmotic, oral dosage form for fertility control
11/03/1993EP0469064B1 Use of c-20 to c-26 aliphatic alcohols for the manufacture of a medicament for the treatment of viral infections
11/03/1993EP0450041B1 Orally administered porphyrins to control intestinal iron absorption
11/03/1993EP0420883B1 Tricyclic 3-oxo-propanenitrile derivatives and process for their preparation
11/03/1993EP0374188B1 Dietary supplement utilizing omega-3/medium chain triglyceride mixtures
11/03/1993EP0374182B1 Biospecific polymers
11/03/1993EP0359790B1 1,4-benzoxazine and 1,4-benzothiazine derivatives and process for their preparation
11/03/1993EP0357788B1 Pyridazinone derivatives
11/03/1993EP0215063B1 PYRIDO (2,3-d )PYRIMIDIN DERIVATIVES
11/03/1993CN1077958A Triazolopyridazine compounds, their production and use
11/03/1993CN1077957A Antibiotic compounds
11/03/1993CN1077956A Methotrexate derivative
11/03/1993CN1077955A Heterocyclic derivatives
11/03/1993CN1077954A 新的苯并吡喃衍生物 New benzopyran derivatives
11/03/1993CN1077953A 乙酸衍生物 Acetic acid derivatives
11/03/1993CN1077952A Carbamate derivatives
11/03/1993CN1077949A "pyridinecarboximidamide compounds and the use thereof"
11/03/1993CN1077888A Cytarabine ocfosfate hard capsule
11/03/1993CN1077887A Compositions of clindamycin and benzoyl peroxide for acne treatment
11/03/1993CN1077886A The use of 7-oxo-7h-pyrido(1,2,3-de)(1,4) benzoxazine-6-carboxylic acids and esters as medicaments
11/03/1993CN1022632C Carboxamide compounds, process for preparing same and pharmaceutical composition containing same
11/03/1993CN1022626C Process for preparation of furan derivatives
11/02/1993US5258552 Cosmetics
11/02/1993US5258518 Antiviral agents, anti-HIV activity
11/02/1993US5258513 Substituted cyclopropylamino-1,3,5-triazines
11/02/1993US5258403 Metallo-organic salt compounds and pharmaceutical uses thereof
11/02/1993US5258402 Imidate derivatives of sulfamates
11/02/1993US5258398 Anticoagulants; platelet aggregation inhibitors
11/02/1993US5258393 Vasodilation
11/02/1993US5258392 3-quinuclidine derivatives
11/02/1993US5258391 For enhancing keratinization by topical application to nails, skin, lips and mucous membranes
11/02/1993US5258390 9-(3 cyanophenyl) hexahydro-1,8 acridinedione
11/02/1993US5258386 Side effect reduction; nonhabit-forming
11/02/1993US5258385 β-Carboline-derived compounds, lamchart benzodiazepine-receptor ligands, having an inverse agonist and antagonist effect on benzodiazepines, and drugs containing them
11/02/1993US5258382 Tetrahydropyrrolo[1,2-a]pyrazine-4-spiro-3'-pyrrolidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
11/02/1993US5258381 Inhibitors of glycosylation of proteins, antiaging agents, discoloration inhibition of teeth and storage stability of foods
11/02/1993US5258379 Method of inhibiting gastric acid secretion with n-arylpiperazines
11/02/1993US5258378 Pyrroloazepine compounds useful as dopaminergic agents
11/02/1993US5258377 2-spirocyclopropyl 4-acylcephems
11/02/1993US5258376 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
11/02/1993US5258375 Composition for the preparation of dosage-form active vitamins D3 containing polyvinylacetal diethylaminoacetate
11/02/1993US5258374 Administering furosemide
11/02/1993US5258373 Synergistic mixture of sulfadimethoxine, ormetoprim and frenolicin-b
11/02/1993US5258372 Mixture of doxycycline or sancycline blocking agent, tetracycline and a carrier
11/02/1993US5258371 Method to reduce connective tissue destruction
11/02/1993US5258185 Highly active, rapidly absorbable formulations of glibenclamide, processes for the production thereof and their use
11/02/1993US5258179 Protection of a food, cosmetic or pharmaceutical product against oxidation
11/02/1993US5258175 Administering acidic dextrin derivative
11/02/1993US5257970 In situ photodynamic therapy
11/02/1993CA2094332A1 Urokinase inhibitors
11/02/1993CA1323877C Triazole derivatives for use as antimycotic agents
11/02/1993CA1323839C Methods for stimulating hair growth
11/02/1993CA1323838C Prostaglandin-lipid formulations
11/02/1993CA1323837C Solid, rapidly disintegrating dosage form
11/02/1993CA1323836C Pharmaceutical compositions having good stability
11/02/1993CA1323835C Stabilised macrolide compositions
11/02/1993CA1323834C Controlled release dosage forms having a defined water content
1 ... 7154 7155 7156 7157 7158 7159 7160 7161 7162 7163 7164 7165 7166 7167 7168 7169 7170 7171 7172 7173 7174 ... 7860